000 01309 a2200397 4500
005 20250517151135.0
264 0 _c20180425
008 201804s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.16733
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShi, Shuang
245 0 0 _aSyndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/FAK-associated signaling pathway.
_h[electronic resource]
260 _bOncotarget
_cJun 2017
300 _a40922-40934 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCSK Tyrosine-Protein Kinase
650 0 4 _aCell Proliferation
_xphysiology
650 0 4 _aFemale
650 0 4 _aFocal Adhesion Kinase 1
_xmetabolism
650 0 4 _aGlioma
_xgenetics
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aSignal Transduction
650 0 4 _aSyndecan-1
_xdeficiency
650 0 4 _aTransfection
650 0 4 _asrc-Family Kinases
_xmetabolism
700 1 _aZhong, Dong
700 1 _aXiao, Yao
700 1 _aWang, Bing
700 1 _aWang, Wentao
700 1 _aZhang, Fu'an
700 1 _aHuang, Haoyang
773 0 _tOncotarget
_gvol. 8
_gno. 25
_gp. 40922-40934
856 4 0 _uhttps://doi.org/10.18632/oncotarget.16733
_zAvailable from publisher's website
999 _c27093775
_d27093775